Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss may increase heart disease risk.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Hair loss lowers quality of life, causing embarrassment, frustration, and sexual rejection.

The article suggests that the view of male baldness as a medical issue is influenced by commercial bias and calls for more unbiased research.

Facial plastic surgeries and aesthetic procedures are becoming more popular in India, with a preference for non-surgical options and effective treatments for facial enhancement and hair loss.

Stem cell treatment improved life quality and sexual function in women with hair loss.

The supplement significantly improves hair density and appearance in people with hair loss.

Ashwagandha serum improves hair health and quality of life in people with hair loss.

Men with a family history of hair loss on their mother's side are more likely to have female pattern hair loss.

Early diagnosis and treatment are crucial for managing female hair loss effectively.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Androgenetic alopecia causes significant psychological distress, especially in women, and requires both medical and psychological support.

Androgenetic alopecia negatively affects quality of life, especially in younger, less educated, single, and rural individuals.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Skin treatment can lower life quality for patients with skin conditions.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Hair loss significantly lowers life quality, especially in young men, with most patients unhappy with treatment effectiveness.

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Hair loss lowers young men's self-esteem, increasing social anxiety and affecting daily life.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.